MethacT Shows Greater Sensitivity to Bronchial Hyperresponsiveness Than Adenosine: Presented at AAAAI
Unregistered User
If this is not your name, click here.
Contact Us | Order Now | Journals | Bookstore | Register a colleague
 
  SEARCH  
News
Bookstore
Medline
The Web
Meetings & Congresses
Complete Doctor's Guide
 


 EXPLORE :
 news  All News
 webcasts All Webcasts
 All cases All Cases
 Meetings All Meetings & Congresses
 Medical All Medical Resources

top





New drugs / indications

English Dictionary

Medical Dictionary

Thesaurus



Warning | Privacy | Awards



 Favourite Journals 

Click here to choose your favourite journals


 Favourite Sites 

Click here to choose your favourite sites


 Languages 



  




MethacT Shows Greater Sensitivity to Bronchial Hyperresponsiveness Than Adenosine: Presented at AAAAI

By Carole VanSickle Ellis

NEW ORLEANS -- March 1, 2010 -- When determining whether a patient has bronchial asthma, it appears that a test with methacholine will be more sensitive than adenosine in clinical practice, according to research presented here on February 27 at the 2010 American Academy of Allergy, Asthma & Immunology (AAAAI) Annual Meeting.

However, isolated instances of bronchial hyperresponsiveness to adenosine may be found and associated to high exhaled nitric oxide (FeNO) levels.

Diego Lumelli, Fundacíon Jiménez Díaz, Madrid, Spain, and colleagues selected a 46-patient study group from patients at the clinic in the J. Sastre Allergy Department on site at the Fundacíon Jiménez Díaz. The patients had a mean age of 40.6 years.

Patients had asthma-like symptoms of coughing, dyspnoea, and/or wheezing. A 2-minute tidal volume method was used for both methacholine and adenosine.

Prior to the study, inhaled corticosteroids had been discontinued for 3 weeks, and B2 inhalers were not used 24 hours prior to the study.

The MethacT test was performed first in all cases. One hour later, the adenosine 5’-monophosphate (AMP) challenge was performed in all cases.

MethacT was positive in 22 of the 46 patients, while 15 had a positive AMP test in 20 minutes (AMP-PC20), and 17 had a positive AMP test in 15 minutes (AMP-PC15).

In 11 of the patients, MethacT resulted in a positive, but AMP-PC15 resulted in a negative, and in 5 patients MethacT was negative, but AMP-PC20 showed a positive. In this final group, 4 out of 5 also showed high FeNO values.

Atopy, Asthma Control Test score, FeNO, and forced expiratory volume in 1 second predictions were not associated with positive results to either test.

The research indicates that MethacT tends to be more sensitive than adenosine in demonstrating bronchial hyperresponsiveness and helping diagnose bronchial asthma.

Isolated hyperresponsiveness to adenosine and the associated high FeNO levels should be considered, however, during the diagnostic process since the results seem to indicate that patients with high FeNO levels might be more sensitive to the adenosine method than the methacholine method.

The research team stated that the 1-hour span of time in between the 2 tests did not appear to interfere with the results.

[Presentation title: Comparison of Bronchial Hyperresponsiveness to Methacholine and Adenosine in Clinical Practice. Abstract 6]

E-mail this page
to a friend or colleague!
To print,
use this version




Any question regarding a medical diagnosis, treatment, referral, drug availability or pricing should be directed to either a licensed physician or to the product's manufacturer.

If you have any technical questions or other concerns about this site, feel free to contact us at webmaster@docguide.com.

All contents Copyright (c) 1995- Doctor's Guide Publishing Limited. All rights reserved.


Employment opportunities | Partnering opportunities